![]() | |
Clinical data | |
---|---|
Other names | Estradiol diundecanoate |
Routes of administration | Intramuscular injection |
Drug class | Estrogen; Estrogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C40H64O4 |
Molar mass | 608.948 g·mol−1 |
3D model (JSmol) | |
| |
|
Estradiol diundecylate (brand name Estrolent), or estradiol diundecanoate, also known as 17β-estradiol 3,17β-diundecylate, is an estrogen and an estrogen ester – specifically, the 3,17β-diundecylate esterofestradiol – which has been marketed in Romania.[1][2][3] It was described, along with a variety of other estradiol esters such as estradiol undecylate, by Karl Junkmann of Schering AG in 1953.[4]
| |||||||
---|---|---|---|---|---|---|---|
ERTooltip Estrogen receptor |
| ||||||
GPERTooltip G protein-coupled estrogen receptor |
| ||||||
|
![]() | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
![]() | This article about a steroid is a stub. You can help Wikipedia by expanding it. |